Source: Sleep and Breathing Conference 2021
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
S. Ryan (Dublin, Ireland). Molecular mechanisms underlying metabolic comorbidities in patients with obstructive sleep apnoea. Sleep and Breathing Conference 2021

Member's Comments

No comment yet.

Related content which might interest you: The metabolic consequences of obstructive sleep apnoea in children Source: Breathe 2009; 6: 111-114 Year: 2009 The puzzle of metabolic effects of obstructive sleep apnoea in children Source: Eur Respir J 2016; 47: 1050-1053 Year: 2016 Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approaches Source: Eur Respir J, 56 (2) 1902295; 10.1183/13993003.02295-2019 Year: 2020 The genetic and cardiovascular aspects of obstructive sleep apnoea/hypopnoea syndrome Source: Eur Respir J 2009; 33: 233-236 Year: 2009 Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Investigation of various factors in obstructive sleep apnea syndrome patients Source: Eur Respir J 2006; 28: Suppl. 50, 194s Year: 2006 The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002 Cardiovascular and metabolic consequences of obstructive sleep apnoea Source: Eur Respir J 2001; 18: Suppl. 33, 519s Year: 2001 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA) Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015 APAP impact on metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 The impact of obstructive sleep apnea syndrome on cardiovascular system in children Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease. Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 Prevalence of thyroid disease in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002